Literature DB >> 16625214

Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans.

D Brassat1, A A Motsinger, S J Caillier, H A Erlich, K Walker, L L Steiner, B A C Cree, L F Barcellos, M A Pericak-Vance, S Schmidt, S Gregory, S L Hauser, J L Haines, J R Oksenberg, M D Ritchie.   

Abstract

Multiple sclerosis (MS) is a common disease of the central nervous system characterized by inflammation, myelin loss, gliosis, varying degrees of axonal pathology, and progressive neurological dysfunction. Multiple sclerosis exhibits many of the characteristics that distinguish complex genetic disorders including polygenic inheritance and environmental exposure risks. Here, we used a highly efficient multilocus genotyping assay representing variation in 34 genes associated with inflammatory pathways to explore gene-gene interactions and disease susceptibility in a well-characterized African-American case-control MS data set. We applied the multifactor dimensionality reduction (MDR) test to detect epistasis, and identified single-IL4R(Q576R)- and three-IL4R(Q576R), IL5RA(-80), CD14(-260)- locus association models that predict MS risk with 75-76% accuracy (P<0.01). These results demonstrate the importance of exploring both main effects and gene-gene interactions in the study of complex diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16625214      PMCID: PMC4339061          DOI: 10.1038/sj.gene.6364299

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  30 in total

Review 1.  Atopy and asthma: genetic variants of IL-4 and IL-13 signalling.

Authors:  I Shirakawa; K A Deichmann; I Izuhara; I Mao; C N Adra; J M Hopkin
Journal:  Immunol Today       Date:  2000-02

2.  Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity.

Authors:  Marylyn D Ritchie; Lance W Hahn; Jason H Moore
Journal:  Genet Epidemiol       Date:  2003-02       Impact factor: 2.135

Review 3.  New strategies for identifying gene-gene interactions in hypertension.

Authors:  Jason H Moore; Scott M Williams
Journal:  Ann Med       Date:  2002       Impact factor: 4.709

4.  Association of IL4R haplotypes with type 1 diabetes.

Authors:  Daniel B Mirel; Ana Maria Valdes; Laura C Lazzeroni; Rebecca L Reynolds; Henry A Erlich; Janelle A Noble
Journal:  Diabetes       Date:  2002-11       Impact factor: 9.461

5.  Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis.

Authors:  B A C Cree; O Khan; D Bourdette; D S Goodin; J A Cohen; R A Marrie; D Glidden; B Weinstock-Guttman; D Reich; N Patterson; J L Haines; M Pericak-Vance; C DeLoa; J R Oksenberg; S L Hauser
Journal:  Neurology       Date:  2004-12-14       Impact factor: 9.910

Review 6.  The risk of determining risk with multivariable models.

Authors:  J Concato; A R Feinstein; T R Holford
Journal:  Ann Intern Med       Date:  1993-02-01       Impact factor: 25.391

7.  Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.

Authors:  Jorge R Oksenberg; Lisa F Barcellos; Bruce A C Cree; Sergio E Baranzini; Teodorica L Bugawan; Omar Khan; Robin R Lincoln; Amy Swerdlin; Emmanuel Mignot; Ling Lin; Douglas Goodin; Henry A Erlich; Silke Schmidt; Glenys Thomson; David E Reich; Margaret A Pericak-Vance; Jonathan L Haines; Stephen L Hauser
Journal:  Am J Hum Genet       Date:  2003-12-10       Impact factor: 11.025

8.  CD83-positive dendritic cells are present in occasional perivascular cuffs in multiple sclerosis lesions.

Authors:  J Plumb; M A Armstrong; M Duddy; M Mirakhur; S McQuaid
Journal:  Mult Scler       Date:  2003-03       Impact factor: 6.312

9.  Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15.

Authors:  James A Traherne; Lisa F Barcellos; Stephen J Sawcer; Alastair Compston; Patricia P Ramsay; Stephen L Hauser; Jorge R Oksenberg; John Trowsdale
Journal:  Hum Mol Genet       Date:  2005-12-01       Impact factor: 6.150

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  20 in total

1.  Synergistic effect of the genetic polymorphisms of the renin-angiotensin-aldosterone system on high-altitude pulmonary edema: a study from Qinghai-Tibet altitude.

Authors:  Yue Qi; Wenquan Niu; Tongchun Zhu; Wenyu Zhou; Changchun Qiu
Journal:  Eur J Epidemiol       Date:  2007-11-07       Impact factor: 8.082

2.  Exploring the performance of Multifactor Dimensionality Reduction in large scale SNP studies and in the presence of genetic heterogeneity among epistatic disease models.

Authors:  Todd L Edwards; Kenneth Lewis; Digna R Velez; Scott Dudek; Marylyn D Ritchie
Journal:  Hum Hered       Date:  2008-12-15       Impact factor: 0.444

3.  A comparison of multifactor dimensionality reduction and L1-penalized regression to identify gene-gene interactions in genetic association studies.

Authors:  Stacey Winham; Chong Wang; Alison A Motsinger-Reif
Journal:  Stat Appl Genet Mol Biol       Date:  2011-01-06

4.  A gene-based method for detecting gene-gene co-association in a case-control association study.

Authors:  Qianqian Peng; Jinghua Zhao; Fuzhong Xue
Journal:  Eur J Hum Genet       Date:  2009-12-23       Impact factor: 4.246

Review 5.  Epistasis and immunity: the role of genetic interactions in autoimmune diseases.

Authors:  Anna M Rose; Lucy C K Bell
Journal:  Immunology       Date:  2012-10       Impact factor: 7.397

6.  Complex gene-gene interactions in multiple sclerosis: a multifactorial approach reveals associations with inflammatory genes.

Authors:  Alison A Motsinger; David Brassat; Stacy J Caillier; Henry A Erlich; Karen Walker; Lori L Steiner; Lisa F Barcellos; Margaret A Pericak-Vance; Silke Schmidt; Simon Gregory; Stephen L Hauser; Jonathan L Haines; Jorge R Oksenberg; Marylyn D Ritchie
Journal:  Neurogenetics       Date:  2006-09-22       Impact factor: 2.660

7.  The effect of retrospective sampling on estimates of prediction error for multifactor dimensionality reduction.

Authors:  Stacey J Winham; Alison A Motsinger-Reif
Journal:  Ann Hum Genet       Date:  2011-01       Impact factor: 1.670

8.  Lack of Association between Glutathione S-Transferase-M1, -T1, and -P1 Polymorphisms and Olanzapine-Induced Weight Gain in Korean Schizophrenic Patients.

Authors:  Young-Min Park; Heon-Jeong Lee; Seung-Gul Kang; Jung-Eun Choi; Jae-Hyuck Cho; Leen Kim
Journal:  Psychiatry Investig       Date:  2010-05-12       Impact factor: 2.505

Review 9.  The genetics of alcohol dependence: advancing towards systems-based approaches.

Authors:  R H C Palmer; J E McGeary; S Francazio; B J Raphael; A D Lander; A C Heath; V S Knopik
Journal:  Drug Alcohol Depend       Date:  2012-07-31       Impact factor: 4.492

10.  Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes.

Authors:  John A Todd; Neil M Walker; Jason D Cooper; Deborah J Smyth; Kate Downes; Vincent Plagnol; Rebecca Bailey; Sergey Nejentsev; Sarah F Field; Felicity Payne; Christopher E Lowe; Jeffrey S Szeszko; Jason P Hafler; Lauren Zeitels; Jennie H M Yang; Adrian Vella; Sarah Nutland; Helen E Stevens; Helen Schuilenburg; Gillian Coleman; Meeta Maisuria; William Meadows; Luc J Smink; Barry Healy; Oliver S Burren; Alex A C Lam; Nigel R Ovington; James Allen; Ellen Adlem; Hin-Tak Leung; Chris Wallace; Joanna M M Howson; Cristian Guja; Constantin Ionescu-Tîrgovişte; Matthew J Simmonds; Joanne M Heward; Stephen C L Gough; David B Dunger; Linda S Wicker; David G Clayton
Journal:  Nat Genet       Date:  2007-06-06       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.